Reply: Sodium-Glucose Cotransporter 2 Inhibitor Use and Outcomes in Transthyretin Amyloid Cardiomyopathy
Related Posts
Hsu YC, Lu M, Llanes A, Keushkerian MJ, Nguyen KL, Johnson K, Altbach MI, Morris HD, DeMarco JK, Deshpande V, Mitsouras D, Saloner D, McNally[...]
Shiraishi Y, Nakamaru R, Kohsaka S, Sandhu AT, Heidenreich PA, Ikemura N, Sawano M, Niimi N, Kimura T, Katsumata Y, Nishiyama T, Ueda I, Takatsuki[...]
Zhang D, Zhao G, Zhang Y, Xu D, Wang S, Wang K, Zhou B, Ling Y, Liu Y, Cui Q, Yin J, Zhu E, Zhao[...]